Trodusquemine – The future of Diet Pills

Trodusquemine is a promising future diet pill that helps to stabilize insulin and leptin levels in the body to effectively suppress appetite.

The latest development in very promising diet pills seems to be coming from the Genaera Corporation, which has recently announced that it is beginning the release of its data from the preclinical trials on trodusquemine (MSI-1436). This drug is currently being considered to be an incredible new treatment for both obesity and type 2 diabetes. This was announced at the Keystone Symposia: Obesity – Novel Aspects of the Regulation of Body Weight, which was held in Banff, Alberta. There, a poster related some of the details of the preclinical trials and was titled “Effect of MSI-1436 (Trodusquemine) on Body Weight and Metabolic Profile in Diet-Induced Obese Rats”. It showed that the right dose of the drug can encourage significant weight loss, as well as lowered fasting blood glucose, cholesterol, and serum triglycerides in participating rates. The researchers from the study reported that this medicine could create dose-dependent changes in the patient’s intake of food which then led to lowered weight and a better tolerance to glucose with an improved lipid profile.

This data is very promising because the diet-induced obese rat form of preclinical trials is a widely accepted jumping off point for gaining approval for this type of drugs. This is also very promising to Genaera, which is now continuing full-tilt with their research about the drug and are now lining up their first human studies with the Trodusquemine MSI-1436 in the hopes that similar results will be achieved.

The drug itself is a form of enzyme that can control the insulin and leptin pathway functions. By doing this, it is believed that the appetite can be reduced in a safe and meaningful way while allowing the blood sugar to remain normal. These initial clinical studies have shown that weight loss does indeed occur at the same time as bettered control over glucose levels. This data aligns with previous research results that had shown that it is possible to lose a large amount of weight without experiencing metabolic rebound, which has been a serious roadblock to calorie-restricted diets. The drug has also shown that it can help with weight loss in obese subjects while improving elevated levels of cholesterol and abnormal glucose metabolism at the same time.

Genaera is continuing its testing in the hopes to be able to achieve FDA approval and release the drug as soon as possible, as it is believed that this diet pill will revolutionize the weight loss industry.